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In a previous study (1) of the classification of the encapsulalus group 
of organisms certain technical difficulties were encountered which made 
a serological differentiation of these bacilli confusing and impracticable. 
The data presented at that time suggested the existence of two types, 
but these were ill defined and comprised only a small number of all the 
strains  studied.  The difficulties attending  the immunological classi- 
fication were ascribed to the failure to obtain potent sera and to the 
interference  of  the  capsule  of  the  organisms  with  agglutination. 
Numerous  other investigators  had  made  unsuccessful  attempts  at  a 
classification,  also,  and  for the most part  they have  attributed their 
failures to one or both of these causes. 
A review of the literature reveals  how contradictory and confusing  the data 
are on the subject.  Kraus (2) and Landsteiner (3) were the first to demonstrate 
agglutination in the encapsulatus group.  Both investigators procured sera which 
agglutinated only in low dilutions.  Sicard (4), Defalle  (5),  Clairmont  (6),  and 
Porges (7) obtained antisera inconstantly.  Immune sera were procured by Klem- 
peter and Scheier (8) and Bertarelli (9) but the sera were not specific and agglu- 
tinated closely related species.  Specific sera were obtained by Friel (10), Coulter 
(11), Small and Julianelle (1), and Ball (12). 
Howard  (13) protected guinea pigs  against  FriedBinder  infection by active 
immunization, but the serum of these animals conferred no passive protection 
on normal animals.  Landsteiner,  Sicard,  and  Clairmont  also  were  unable  to 
demonstrate protective antibodies in  the sera of immunized  animals.  Perkins 
(14)  found that guinea pigs surviving a  spontaneous Friedl~nder epidemic ac- 
quired immunity against the organism  isolated during the epidemic.  In a later 
paper (15) he states that  "animal inoculation, immunization and agglutination 
show results which are far too variable to admit of them as means for classifica- 
tion." 
Limiting their work to the differentiation of the FriedlAnder and rhinoscleroma 
organisms,  Erben  (16),  Ballner and  Reibmayr (17), and  Galli-Valerio  (18, 19) 
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could determine no serological  differences  between these organisms.  Goldzieher 
and Neuber (20),  on the other hand, obtained fixation reactions with B. rhino- 
scleromatis, using  serum from patients  suffering  from rhinoscleroma and  from 
rabbits immunized to the rhinoscleroma bacillus,  but they were  not  successful 
when Friedliinder's bacillus was used as antigen With the same sera.  Babes (21) 
produced in rabbits an agglutinating serum of low titer against a strain of B. rhino- 
scleromc~tis.  Sdrawosmysloff  (22) found no complement-fixing antibodies in the 
serum of a rhinoscleroma patient. 
Schmidt  (23),  using  the  serum of a  patient convalescent  from Friedl'~nder 
infection of the lung,  and the organism isolated from the sputum and from the 
lung by direct puncture,  observed an "amorphous" agglutination.  In this in- 
stance, no immune properties were demonstrable until after the  1st  month of 
illness,  when  agglutination,  bacteriolysis,  and  thread  reaction  were  observed. 
Wolf (24) isolated a  strain of Friedl~inder's  bacillus from the urine of a  patient 
whose serum agglutinated equally well the homologous strains and several stock 
laboratory ones in dilutions of 1:2000 and 1 : 5000. 
Porges attributed the difficulty  of immunization with encapsulatus  strains to 
the  presence of capsules  which  he  thought  interfered also with  agglutination. 
Consequently he devised a method by which the capsular material was hydrolyzed 
by heating suspensions  of the bacteria in weak acid.  With yon Eisler  (25) he 
showed that after destruction of the capsule immune sera could be obtained and 
that agglutination was facilitated in this way.  Streit (26) and Beham (27) took 
exception to the method because suspensions  so treated were apt to clump spon- 
taneously.  They  effected  decapsulation  by  cultural  methods,  and  obtained 
agglutination regularly. 
Fitzgerald  (28) found that immunization of rabbits with B.  rhinoscleromatis 
yielded a  potent  serum which  agglutinated four other strains of the  organism 
equally well.  These strains were  agglutinated only when capsule-free.  Small 
and JulianeUe  observed that  capsule-bearing strains agglutinated only in  high 
concentrations of immune sera, and the flocculation  resulting under these condi- 
tions gave a compact disk at the bottom of the tube with a clear supernatant fluid. 
Capsule-free  strains on the other hand agglutinated in serum dilutions as high as 
1:2500  and gave a finely granular precipitate which was easily broken up.  The 
encapsulated strains, moreover, adsorbed the specific agglutinins from the immune 
sera, while capsule-free  strains did not. 
It  becomes  evident  from  this  review  of  the  literature  that  great 
confusion  exists as  to  the  immunological identity of members of the 
encapsulatus  group.  The  impression is that  agglutination not only is 
all.cult,  but  unreliable  and  not  sharply differential.  It seemed not 
unlikely, however, that the application to this group of the principles 
governing the  immunological relationships  of pneumococci and  their 
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among the encapsulated bacilli.  This newer concept of the bacterial 
cell (29-34) involves two separable and distinct constituents--the one 
a  polysaccharide,  the  soluble  specific  substance,  which  endows  the 
cell with  type specificity; the other a  protein  substance,  which,  re- 
gardless of type derivation,  exhibits immunologically only the com- 
mon  and  undifferentiated characteristics  of  the  species.  The  dis- 
sociation  of the polysaccharide from the  cell deprives the organism 
of its  type-specific antigenic power.  In  general, antipneumococcus 
serum  contains  both  the  type-specific and  the  species-specific anti- 
body; the occurrence of the latter depending upon the extent of the 
dissociation  of  the  antigenic  complex,  which  may  take  place  both 
in vitro  and in vivo.  The presence of the protein antibody in appre- 
ciable  amounts  may  therefore mask  and  sometimes  obliterate  the 
type specificity of an  organism.  Moreover, under unfavorable con- 
ditions, these organisms are known to lose the function of elaborating 
the  soluble  specific  substance--a  condition resulting in loss of type 
specificity, capsule formation, and accompanied by loss of virulence. 
These degraded strains  lose  the property  of  stimulating  the  type- 
specific antibody and as  antigen provoke only the common protein 
response  (also  Stryker (35),  Reimann  (36),  Amoss  (37)).  In  other 
words,  type  specificity is  demonstrable only when  the antisera  are 
dominantly type-specific and the strains to  be  agglutinated must be 
not degraded but encapsulated.  Stripping an organism of its capsule 
therefore will minimize the specific serologic reactivity of the organ- 
ism.  It was with this conception, then, that the problem of the classi- 
fication of the Frledl~tnder bacilli was subjected to further analysis. 
]~XPERIMI~.NTAL. 
Strains of Microorganisms.--The organisms used in this investigation were all 
members of the encapsulatus group as determined by their individual, cultural, 
staining, and biochemical characteristics.  They had been isolated at different 
times and places within the past 6 years.  Strains E and K were isolated from 
guinea pigs with pneumonia; Strains H1 and H2 were derived from infections in 
horses;  and the remaining  strains, from human sources,  the majority  of them having 
been associated with lobar pneumonia.  Two strains of F~ncapsulatus  granulomatis, 
and two strains of B. aeroge~s were included in the agglutination tests as a control 
of specificity.  All the strains had in common the production of mucoid, gummy 
growth, though there were variations in this respect by the individual strains. 116  CLASSIFICATION  OF  ENCAPSULATUS  PNEUMONI3E 
Immunization .--Normal rabbits were bled before immunization was begun and 
the normal sera were pooled and used for control in the subsequent tests.  The ani- 
mals were  immunized by intravenous injections of suspensions of the heat-killed 
encapsulated organisms.  Small  doses  were  injected in  the  beginning and  the 
amount increased during the course of the injections.  Immunization was effected 
by injecting the organisms on 3 successive days, followed by a rest period of 4 days. 
Before each course of injections, the titer of the serum of each rabbit was deter- 
mined; and when the serum showed no further increase in titer, immunization was 
discontinued.  The rabbits were bled 9 or 10 days after the last injection.  By this 
method, an efficient agglutinating serum was obtained in from 4 to 5 weeks. 
Agglutination.--Agglutinations  were  conducted  with  saline  suspensions  of 
living bacilli kept without  preservative.  The various suspensions were diluted 
to an equal turbidity before being used for the test.  Incubation was  carried out 
for 2 hours at 37°C. in the water bath, and final readings were made after the tubes 
had been in the ice box overnight.  In the more concentrated sera, positive results 
were usually observable within a  few minutes.  In agglutinin adsorption tests, 
heat-killed organisms were used. 
Protection.--The protective power of the sera was determined by injecting white 
mice intraperitoneally with a mixture of 0.2 cc. of the serum and varying dilutions 
of a broth culture of the organism, both being brought to a volume of 0.5 cc. with 
sterile broth.  The culture used was grown from 4 to 6 hours.  The mice were kept 
under observation for 6 days and those surviving for  this period were considered 
effectively protected. 
Predpitin Tests.--In the precipitin tests 0.2 cc. of immune serum diluted to a 
volume of 0.5 cc. with salt solution was added to an equal volume of increasing 
dilutions of the  soluble specific substance  of Friedl~nder's bacillus.  The  mix- 
tures were incubated for 2 hours at 37°C. in the water bath.  Final readings were 
made on the following morning after the mixtures had been overnight in the ice box. 
Thread Reaction.--In  performing these tests, dilutions of the various sera were 
made in sterile broth.  The serum broth tubes were then inoculated with 0.1  cc. 
of a 4 hour culture of the organisms to be studied and incubation was carried on 
overnight, for a period of 16 to 18 hours. 
Agglutination. 
Rabbits were immunized as described to seven of the strains studied. 
Use was also made of Type II antipneumococcus serum , in view of the 
recent work of Avery, Heidelberger, and Goebel (38). 
The  type-specific agglutinations  are  characteristic  and  result  in  a 
voluminous,  compact  disk  at  the  bottom  of  the  tube  with  a  clear 
supernatant  fluid.  In  the lesser dilutions the  flocculation occurs im- 
mediately and becomes apparent  even before incubation. LOUIS  A.  JULIANELLF. 
TABLE  I. 
Cross-Agglutination  Reactions  with  Strains  of Friedlander's  Bacillus. 
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~5.~  Immune sera--fmal  dilution  I:  3. 
"~  F5  Sc  F2  F6  Pn. II  F10  FI1  F12 
F3  ++++  ++++  ....... 
F5  ++-b+  +-t-+ +  ....... 
F8  ++++  ++++  ....... 
F9  ++++  ++++  ....... 
F15  ++++  ++++  ....... 
F18  ++++  ++++  ....... 
F19  ++++  ++++  ....... 
F20  ++++  ++++  ....... 
F21  ++++i++++  ....... 
F23  ++++  ++++  ....... 
F25  ++++  ++++  ....... 
Bu  ++++  ++++  ....... 
Sc  ++++  ++++  ....... 
Sm  ++++  ++++  ....... 
st  ++++++++  ....... 
F2  --  --  ++++  ++++  ++++  .... 
F6  --  --  ++++  ++++  ++++  .... 
E  --  -  ++++  ++++  ++++  .... 
HI  --  --  ++++  ++++  ++++  .... 
H2  --  -  ++++  ++++  ++++  .... 
K  --  --  ++++  ++++  ++++  .... 
FIO  .....  ++++  --  --  -- 
M  .....  ++++  --  --  -- 
R  .....  ++++  -  -  -- 
Fll  ......  ++++  --  -- 
FI2  .......  +++4  -- 
F1  ......... 
F13  ......... 
F22  ......... 
F24  ......... 
G1  ......... 
G2  ......... 
A  ......... 
W  ......... 
+++  +  indicates complete,  compact  agglutination with  clear  supernatant; 
-  indicates no agglutination. 
Strains G1 and G2 are strains of granulorna bacillus, and A  and W, aerogenes. 
None of these strains were agglutinated byType  I  or III antipneumococcus sera. 
The agglutination titer of these sera was as follows:  F5,  1:40; St,  1:40; F2,  1:80; 
F6,  1:40; Pn. II, 1:40; F10,  1:40; Fll,  1:160; FI2, 1:80. 118  CLASSIFICATION  OF ENCAPSULATUS  PNE~ONI~: 
The  cross-agglutination  reactions  are  summarized  in  Table  I. 
It  becomes evident  from  the  data  that  anti-Friedl~nder  sera  cause 
a  highly  specific agglutination  which  serves  to  define  distinct  type 
relations.  Three types are revealed.  Of the thirty strains included in 
TABLE  II. 
A gglutinin Adsorption Reaction. 
Result of Agglutination  with TypeA Serum after Adsorption  with Strains of Homol- 
ogous and Heterologous Types. 
Serum Type A (FS). 
Strain.  Type. 
Un~lsorbed. 
F5 
A  ++++  -- 
F5  A  ++++  -- 
F8  A  ++++  -- 
A  ++++  -- 
F15  A  ++++  -- 
H8  A  ++++  - 
F19  A  ++++  -- 
F20  A  ++++  -- 
~1  A  ++++  -- 
F~  A  ++++  -- 
~5  A  ++++  - 
Sc  A  ++++  - 
Sm  A  ++++  -- 
st  A  ++++  - 
Bu  A  ++++  -- 
E  B  --  -- 
Adsorbed by strains of 
Type A.  Type B. 
E  F15  Sc  Sm 
m 
Bu 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
The  final dilution  of serum  in these  tests  was  !  : 5. 
+  ++  +  indicates  comp'.ete,  compact  agglutination;  -  indicates  no  agglu- 
tination. 
the survey, twenty-four fall into one or another  of these types.  For 
the sake of convenience,  these groups will be referred to as Type A, 
which is composed of fifteen strains; Type B, which is composed of six 
strains;  Type  C,  which  comprises  three  strains.  The  remaining  six 
cultures, against  four of which no sera were prepared, are placed in a LOUIS A.  JULIANELLE  119 
heterogeneous group, Group X.  It is not unllkely that, with an ex- 
tension  of this  study so as  to include a  greater  number of strains, 
TABLE  III. 
Agglutinin Adsorption Reaction. 
Results of Agglutination  with Type B Serum after Adsorption with Strains of Homol- 
ogous and 11eterologous Types. 
F2 
F6 
E 
K 
H1 
H2 
Sc 
B 
B 
B 
B 
B 
B 
A 
Serum Type B (F2). 
Adsorbed by strains of 
e~ 
Ty~B. 
F2  E 
++++ 
++++ 
++++  - 
++++ 
++++ 
++++ 
m 
TypeA. 
Sc ¸ 
++++! 
++++ 
-  ++++ 
++++! 
++++ 
++++ 
il 
F2  B 
F6  B 
E  B 
K  B 
H1  B 
H2  B 
Sc  A 
Serum Type B (F6). 
++++] 
++++ 
++++ 
++++ 
++++ 
++++ 
Adsorbed by strains of 
Type B.  T~  A. 
F2  F6  Sc 
~++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
TABLE  IV. 
Agglutinin Adsorption Reaction. 
Results of Agglutination with Type C Serum after Adsorption with Strains of Homol- 
ogous and Heterologous Types. 
Str~. 
FIO 
M 
R 
Sc 
Tyl~. 
C 
C 
C 
A 
Serum Type C (FI0). 
Adsorbed by strains of 
Unadsorbed.  Type C,  Type A. 
Sc 
++++ 
++++ 
++++ 
FI0  M  R 
++++ 
++++ 
++++ 
additional  types  may  be  demonstrated  among  the  heterogeneous 
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The B type of the Friedl~nder bacillus is similar immunologically  to 
Type II Pneumococcus.  Avery, Heidelberger, and  Goebel have al- 
ready called attention  to  this  relationship.  It will be recalled that 
they showed that certain strains of Friedl~nder's bacillus, now desig- 
nated as Type B, possess specific polysaccharides which, both in chemi- 
cal  and immunological properties,  are  so  similar as  to  show  cross- 
agglutination and protection, but  no  reciprocal adsorption of anti- 
bodies.  It is seen that the six strains of this type react as well with 
Type II antipneumococcus serum as they do with their homologous 
sara. 
TABLE  V. 
Protective Action of Anti-Friedl~inder Serum, Type A, against Strains of Homologous 
and Heterologous Types. 
Amount of 
culture. 
10-6 
10-4 
10-6 
10  ~ 
10-6 
I0-6 
I0-7 
Immune  serum 
Type A. 
co. 
0.2 
0.2 
0.2 
0.2 
Strains of Friedlitnder bacillus. 
Type A.  Type B. 
F$  E 
D.  23 hrs. 
S. 
c¢ 
cc 
D. 15 hrs. 
"  20  " 
~c  40  ct 
F9  Sc 
D.  48 hrs.  D.  24 hrs. 
S.  S. 
~c  cc 
D. 24 hrs.  D. 40 hrs. 
"  45  "  "  45  " 
"  46  "  "  46  " 
D. 16 hrs. 
~  40  ~ 
~  40  Ic 
D. 16 hrs. 
"  44  " 
~c  40  ~l 
S. indicates that the animal survived; D., that the animal  died.  The numerals 
represent the number of hours before death occurred. 
A gglutinin Adsorption. 
Further evidence of the specificity of the types just mentioned was 
obtained by agglutinin adsorption tests.  The type sara were adsorbed 
with heat-killed suspensions of both homologous  and heterologous type 
strains.  When all the antibodies had been removed for the adsorbing 
strain,  the sara  were  tested for  the presence of agglutinins for  the 
other strains of the homologous type. 
The data summarized in Table II  show that  Serum F5  (Type A) LOUIS  A.  JULIANELLV.  121 
was adsorbed with five homologous strains, F5, Sc, F15, Sm, and Bu, and 
in each case  the  agglutinins were  completely adsorbed.  Adsorption 
with a  heterologous strain,  E, left untouched the agglutlnins in this 
serum.  When Serum F2 (Type B) was adsorbed with Strains F2 and 
E, homologous strains, agglutinins were removed from the serum not 
only for the adsorbing strains but for all the strains which were ag- 
glutinated by the unadsorbed serum.  Strain Sc, a heterologous type, 
however, exerted no influence on the agglutination of the strains of the 
type serum.  Similarly, adsorption of Serum F6  (also Type B)  with 
TABLE  VI. 
Protective Action of Anti-Friedli~nder Serum Type B, against Strains of Homologous 
and Heterologous Types. 
Amount of 
culture. 
10--2 
10  4 
10  4 
10--6 
10-e 
10  ~ 
10  ~ 
lO-r 
Immune  serum 
Type B. 
¢:C. 
0.2 
0.2 
0.2 
0.2 
0.2 
Strains of Friedlttnder bacillus. 
Type B.  Type A. 
F6  F9 
D. 23 hrs. 
S. 
lc 
~c 
D. 44 hrs. 
"  48  " 
S. 
K  E 
D. 40  hrs.  D. 40  hrs. 
S.  S. 
D. 16  hrs.  D. 16  hrs. 
"  18  "  "  44  " 
"  21  "  "  44  " 
D.  19 hrs. 
"  23  " 
"  92  " 
~¢  40  cc 
D. 24 hrs. 
cc  40  (~ 
homologous strains removed all agglutinins for members of this group, 
whereas, adsorption by Sc, a heterologous strain, again had no effect 
on  the  agglutinin  titer  (Table  III).  Serum F10  (,Type C)  was no 
longer agglutinating for its three homologous strains after adsorption 
had  taken place by  Strains  F10,  M,  and  R.  Strain  Sc  (Type A), 
however, adsorbed out none of the agglutinins (Table IV).  The results 
obtained by the method of agglutinin adsorption constitute conclusive 
evidence that  the  types  disclosed by agglutination with anti-Fried- 
l~inder sera are real types. 122  CLASSIFICATION  0~"  ENCAPSULATUS  PN'EUMONI2E 
Protection Tests. 
That  Friedl~nder bacilli  are  separable  into at least three specific 
types, as demonstrated by the reactions of agglutination and agglu- 
finln  adsorption  is  a  fact  which gains  further demonstration  from 
~imal  protection  tests.  It  is  evident  from  the  data  presented in 
Tables V and VI that the protective action of the type immune sera 
reveals  type  specificity  in  the  case  of  Friedl~tnder  bacilli  just  as 
sharply as does agglutination.  Type A  serum (Strain F5)  protected 
mice against homologues of this type to an infective dose of 0.0001  cc. 
when the cultures themselves killed white mice regularly in a dilution 
of 0.0000001  cc.  within 48  hours.  On  the other hand it  offered no 
protection against an infection with an organism of a  different type. 
Type B serum (F2) protected against infection by three strains of the 
homologous type to 0.0001 cc. when the cultures as such were fatal to a 
dilution of 0.0000001  cc.; yet this serum offered no protection against 
infection of a different type. 
It was not possible to obtain data for the protective power of Type 
C sera.  The three cultures of this type were avirulent for mice, and, 
despite  numerous animal passages,  the lethal dose could not be in- 
creased.  The  strains  were all  capsule-bearing and no  "R"  colonies 
could be demonstrated by plating directly from the peritoneal fluid of 
infected mice. 
It  is  obvious  from the results of the protection  test  that  certain 
anti-Friedl~nder sera offer definite protection against infection of the 
organisms and  that  the protection is  type-specific.  The protective 
power of these sera was not as high as had been anticilmted however. 
Avery, Heidelberger, and  Goebel obtained  a  greater degree of pro- 
tection against Type B infection; but there is no essential discordance 
between their results and ours, since our animals did not receive as 
intensive an immunization. 
Thread Reaction. 
Still further proof of the type specificity of the Friedl~tnder organ- 
isms  was  obtained  by means  of the thread reaction.  This reaction 
depends upon the character of the growth of an organism in homolo- 
gous immune serum.  Although the mechanism of the reaction may be LOUIS  A.  ~YLIAN'ELLE  123 
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the same as that involved in agglutination, it is usually more delicate 
than  agglutination,  and frequently positive results are obtained  at a 
dilution of serum beyond the range of agglutination. 
The findings are presented in  Table VII.  It is seen  that  a  strain 
gives  the  thread  reaction  only when  it  is  grown  in  immune  serum 
of the homologous type.  The reaction extends over the same range of 
dilutions as agglutination.  It was expected that the thread reaction 
would be detectable in greater dilutions, but the growth of the organ- 
ism  is  so  profuse  as  probably  to  obscure  the  clumped  growth  that 
might occur at the higher dilutions. 
Precipitin  Reaction. 
It has been stated earlier in this paper that  a  part  of the  difficulty 
in  demonstrating  types by  serological  reactions  in  the  encapsulatus 
group has  been  explained  on  the  basis  that  capsules inhibit aggluti- 
nation  and  interfere  with  agglutinin  formation  in  the  body.  The 
methods which were  devised  to  strip  the  organism  of its  capsule, at 
the same time removed from the organism its specificity. 
The first workers considered the capsule to be a nucleoprotein (39, 7, 28,  11). 
The chemical nature of the substance was studied by Rettger (40), who considered 
it a  glycoprotein,  possibly  a  pseudomucin.  Toenniessen  (41) isolated from  a 
strain of Friedliinder's  bacillus a polysaccharide  which yielded on hydrolysis an 
osazone,  probably of galactose.  Kralr~r  (42) isolated a  polysaccharide  which 
on inversion yielded galactose.  None of these investigators, however, recognized 
the  relationship  between  the  chemical  nature  and  biological  specificity  of the 
capsular material. 
Recently Mueller,  Smith,  and  Litarczek  (43) derived  from  a  Friedliinder 
bacillus a carbohydrate-containing material which reacted to a very high dilution 
of homologous immune serum.  Heidelberger, Goebel, and Avery (44, 38) obtained 
a nitrogen-free polysaccharide  from Strain E  (Type B) which reacted specifically 
with immune serum of the homologous type in dilutions of 1: 4 millions.  Blake 
(45) was the first, and as far as we know the only one, to show the appearance 
of the soluble specific substance  of Friedliinder's  bacillus in the blood and urine 
during an active infection.  Although he could demonstrate no agglutinins in the 
serum of a patient, he found increasing  amounts of the soluble specific substance 
of Friedlttnder's  bacillus in both blood and urine.  This is an interesting example 
of similarity in Friedl~inder and Pneumococcus pneumonia, since it is possible in 
both infections  (46) to demonstrate the presence of the soluble specific substance 
of the causative organism in the blood and urine of patients suffering from severe 
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Since  the  relation  of  capsular  material  and  specificity has  been 
recognized it  seemed  desirable  to  determine  the  action  of immune 
sera of the different types on the isolated specific substance of Fried- 
l~inder bacilli.  Nitrogen-free  polysaccharides of Strain  Sc  (Type A) 
and Strain E  (Type B)  were  obtained  ~ and  cross-precipitin reactions 
were carried out in the usual manner.  The amount of immune serum 
was kept  constant at  0.2  cc.  while  the  polysaccharide was  used  in 
increasing dilutions. 
TABLE  VIII, 
.Precipitation of the Soluble Specific Substance o/ Friedlander Bacilli by Immune 
Sera of Homologous and Heterologous Types. 
Anti-Friedl~nder 
serum. 
Type A  F5 
'Sc 
'i 
Type B  F2 
~F6 
IE 
Type C  FI~] 
Group  X  FII 
FI2 
Normal  serum. 
Type  A  soluble  specific  substance. 
++ 
++ 
++  ± 
++ ++ + ± 
I 
--] 
--,E  i 
m 
m 
!_i 
Type  1] soluble  specific  substance. 
+ 
+ 
+++ 
I 
++ 
++ 
+++ 
++ 
++ 
+++ 
R 
i-- 
I 
i-  +++++- 
+  +±-- 
+++  ±  -i- 
[--  --  -- 
I 
--  ]--  -- 
__  l  ..... 
i 
+ + + +  indicates heavy compact, disk precipitate; + + +, marked disk pre- 
cipitate; ++, thin, film-like  scale; +, ground glass turbidity; ~:, slight turbidity; 
-,  no reaction: 
* These figures  represent dilutions in thousands. 
The results of the precipitation tests are presented in Table VIII, 
and they show that the polysaccharide of each type reacts only with 
immune sera of the corresponding type and that precipitation occurs 
at a  high dilution of the soluble specific substance.  Further evidence 
to be reported in a subsequent publication will show that the organism 
1  The polysaccharides  were obtained through the courtesy of Dr. Heidelberger 
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without its capsule is devoid of type specificity.  It becomes obvious, 
therefore, that by removal of the capsule, specificity is lost. 
DISCUSSION. 
Although numerous attempts have been made by various investi- 
gators to classify the Friedliinder group of bacilli on the basis of sero- 
logical  reactions,  confusion rather  than  system  has  resulted.  The 
newer conception of the immunological relationships of the capsular 
and somatic substances of the bacterial cell has furnished us, in part 
at least,  with an  explanation of the earlier failures.  The principles 
involved are those brought out by the immunochemical studies on the 
type specificity of Pneumococcus, which have been carried on in this 
laboratory.  The work has revealed a cellular mechanism in which two 
distinct and separable substances are concerned in the antigenic and 
serological behavior of  the cell.  One  of these, the capsular or ecto- 
plasmic layer of the cell, is the soluble specific substance which is now 
identified as a polysaccharide and is chemically different for each of the 
fixed  types  of  Pneumococcus.  The  differential  specificity  of  the 
bacterial types is dependent solely upon the presence of this substance. 
That the carbohydrate  fraction of the Friedliinder bacillus is the 
substance  which  determines  specifidty  among  organisms  of  the 
encapsulatus group  has  been  demonstrated  in  the  present  study, 
and in  other papers from this laboratory.  Removal of the capsule 
either by hydrolysis or by cultural methods results in a loss of speci- 
ficity of the organism. 
The second constituent of the Pneumococcus cell is  the somatic 
protein substance which, regardless of type derivation, exhibits im- 
munologically only the common and undifferentiated characteristics of 
the species.  Immunization by a  number of workers with a  capsule- 
free Friedl~inder bacillus has yielded a serum which reacted with cap- 
sule-free strains of any type of these organisms. 
Antigenically  , the polysaccharide of the bacterial cell is inert.  How- 
ever, in the form in which it exists in the cell, this carbohydrate com- 
plex is the dominant and effective antigen yielding on {mmunization 
the corresponding type-specific antibody.  It is now recognized that 
cell dissolution, whether occurring spontaneously in the body or arti- LOLrlS A,  JULIANELLE  127 
ticially in vitro, is accompanied by more or less antigenic dissociation. 
The result of this process is reflected in  the  immune serum by the 
increasing amount of non-specific antibody with diminution or com- 
plete loss of type-specific response. 
In previous studies it was observed that prolonged immunization 
induced a  serum of high fiter for the Friedl~tnder organism, but that 
the serum agglutinated as well a number of organisms which were un- 
able  to  remove agglutinins of the specific type by adsorption of the 
serum.  Other workers also produced high titered sera at the expense 
of specificity. 
The lack of recognition of two distinct antibodies in a single immune 
serum, each specifically reactive with only one of the cell constituents, 
and  conversely the failure  to  distinguish the type-specific from the 
species-specific antigen of the cell, explain some of the difficulties en- 
countered in  the  earlier  efforts at  classification of the encapsulatus 
group. 
In a  later paper the immunological relationships of these two con- 
stituents  the  protein  and  carbohydrate,  and  of  encapsulated  and 
capsule-free strains of the Ftiedl~tnder bacillus, will be described. 
SUMMARY. 
A biological classification has been made of thirty strains of Fried- 
l~nder's bacillus.  This  study reveals  that  there  exist  among these 
strains three sharply defined and specific types and one heterogeneous 
group.  The  three  types are  Type A,  fifteen  strains;  Type B,  six 
strains; Type C, three strains; and Group X, six strains.  The agglu- 
tination,  agglutinin  adsorption,  protection,  thread,  and  precipitin 
reactions have  been  employed in  the working out of this classifica- 
tion, and the types have been proved highly specific by means of each 
serological test. 
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